Dodinot B
Centre Hospitalier Universitaire de Nancy.
Ann Cardiol Angeiol (Paris). 1990 Dec;39(10):597-605.
The term "synchronous pacemaker (SPM)" is used to describe all pacemakers of which the frequency can be accelerated by means of a sensor other than the sinus node. The most commonly used system is the detection of changes in physical activity by means of a quartz crystal included in the casing. Changes in respiratory volume, the respiratory rate, the QT interval or central temperature have been less successfully used. Single and double-chamber (DC) synchronous pacemakers exist. Ventricular single-chamber synchronous pacemakers (VVIR) are primarily intended for active patients in a state of chronic atrial fibrillation or, secondarily, in cases in which the insertion of an atrial electrode raises difficulties. The single-chamber atrial synchronous pacemaker (AAIR), or preferably the double-chamber equivalent (DDDR) is intended for the correction of chronotropic failure, whether this is primary or induced by bradycardiac antiarrhythmic medication. AVB should be treated by double-chamber simulation designed to pick up P waves. The value of the synchronous pacemaker in these patients is that it makes it possible to partially offset the loss of atrial systole in cases of ventricular fibrillation by a synchronous pacemaker (pacemaker programmed to shift from DDD to VVIR). The setting of the SPM is fairly complex and calls for exercise tests. Iatrogenic acceleration is not unusual and must be identified by long-term recordings. All these pacemakers will here include a "synchronous" option, which may be of variable efficacy. It is up to the clinician to use them appropriately, and not automatically, remembering that the best sensor is the sinus node and that synchronous pacemakers are only second best.
术语“同步起搏器(SPM)”用于描述所有频率可通过窦房结以外的传感器加速的起搏器。最常用的系统是通过外壳内的石英晶体检测身体活动的变化。呼吸量、呼吸频率、QT间期或中心温度的变化使用得不太成功。单腔和双腔(DC)同步起搏器均存在。心室单腔同步起搏器(VVIR)主要用于慢性心房颤动状态下的活跃患者,其次用于插入心房电极存在困难的情况。单腔心房同步起搏器(AAIR),或者更优选双腔等效起搏器(DDDR),用于纠正变时性功能不全,无论其是原发性的还是由缓慢性抗心律失常药物引起的。房室传导阻滞应通过旨在检测P波的双腔模拟进行治疗。同步起搏器在这些患者中的价值在于,在心室颤动的情况下,它可以通过同步起搏器(编程为从DDD转换为VVIR的起搏器)部分抵消心房收缩的丧失。SPM的设置相当复杂,需要进行运动测试。医源性加速并不罕见,必须通过长期记录来识别。所有这些起搏器在此都将包括一个“同步”选项,其效果可能各不相同。临床医生应适当而非自动地使用它们,要记住最好的传感器是窦房结,而同步起搏器只是次优选择。